BioNTech and Bristol Myers Squibb have agreed to jointly develop and commercialize BioNTech's BNT327 cancer-drug candidate in a deal potentially worth more than $11 billion to the German drugmaker.

Australian investment manager Washington H. Soul Pattinson and building-products maker Brickworks agreed to merge into a single company. Andrew Witty, who largely led the U.S. healthcare giant from ...

Destination NSW ditches the traditional city-sell in favour of a creative, emotion-driven campaign inviting travellers to ...

Tourism advertising is getting a shake up, with Destination NSW ditching the traditional city-sell in favour of a creative, emotion-driven campaign that invites travellers to experience Sydney not ...

Interbrand's Nancy Villanueva on why global brands must be on the ground, employ local people, and work with local partners ...

From purple press to AI lullabies and floating pandals, Havas is entering Cannes with cause-led campaigns that merge culture, ...

Even if you weren't around yet when the ad debuted, there's a good chance you know this 1970s McDonald's Big Mac jingle and ...

As GenAI becomes a prominent fixture in our everyday digital interactions, the way consumers search is undergoing a profound ...

The Nigerian economy currently faces numerous challenges, from inflation and unemployment to rising living costs. Many Nigerians are turning to side hustles, part-time jobs or small businesses done ...

For Kevin Doherty, owner and operator of the New York City-based Tara Mór restaurant and its sister bar, Tara Rose ...

Many of us have experienced the unpleasant and sometimes embarrassing symptoms of gastrointestinal upset. However, talking ...

Meta Platforms Inc. (NASDAQ: META) is set to revolutionize the advertising industry by introducing a fully automated ad ...